US FDA Adds New Faces To Vaccines Adcomm For Pfizer/BioNTech COVID-19 Review

 
• By Derrick Gingery

The Vaccines and Related Biological Products Advisory Committee will have five more members than were present for the 22 October meeting on coronavirus vaccine development and approval issues.

FDA Advisory Committee Feature image
The 10 December Vaccines and Related Biological Products Advisory Committee meeting runs from 9 a.m. to 5:15 p.m. • Source: Pink Sheet illustration

More from US FDA Performance Tracker

More from Regulatory Trackers